PMC4298869_01
The infant at initial presentation with extensive hemangioma involving most of the right cheek and right eyelids. There were five ulcerated, hemorrhagic spots which had been covered with dressings by the parents.
wjps-4-079-g001.jpg
PMC4298869_01_wjps-4-079-g001.jpg
F1
A 29 days old Pakistani female infant was brought by parents to our outpatient department with two weeks history of a rapidly progressing purplish color, raised cutaneous lesion with bosselated surface involving most of the right cheek and right eyelids with associated inability to open the right eye. (Figure 1). Clinical examination of the infant revealed features suggestive of a large hemangioma on the right face (Figure 1), three similar hemangiomas on the right side of the palate and adjoining buccogingival surfaces (Figure 2), and a small hemangioma on the right third toe (Figure 3).
Three hemangiomatous lesions on the right side of palate and adjacent buccogingival surfaces could be also be visualized as the child cried.
wjps-4-079-g002.jpg
PMC4298869_01_wjps-4-079-g002.jpg
F2
Clinical examination of the infant revealed features suggestive of a large hemangioma on the right face (Figure 1), three similar hemangiomas on the right side of the palate and adjoining buccogingival surfaces (Figure 2), and a small hemangioma on the right third toe (Figure 3).
Small hemangioma was also present on the right third toe.
wjps-4-079-g003.jpg
PMC4298869_01_wjps-4-079-g003.jpg
F3
Clinical examination of the infant revealed features suggestive of a large hemangioma on the right face (Figure 1), three similar hemangiomas on the right side of the palate and adjoining buccogingival surfaces (Figure 2), and a small hemangioma on the right third toe (Figure 3).
Three days after initiation of the propranolol therapy, there was visible alteration in the color of the lesion, softening in texture and the infant could slightly open the right eye.
wjps-4-079-g004.jpg
PMC4298869_01_wjps-4-079-g004.jpg
F4
The infant was subsequently sent home with advice to mother regarding adherence to appropriate dosage regimen and a follow up visit after 72 hours (Figure 4). 
There was considerable improvement after completing four weeks therapy.
wjps-4-079-g005.jpg
PMC4298869_01_wjps-4-079-g005.jpg
F5
The treatment was stopped after four weeks when there was a sustained halt in the growth of the hemangiomas (Figure 5).